Objective: Although the adaptive immune response to SARS-CoV-2 has been characterised in the acute and early convalescent phase of the disease, few studies explore whether natural infection elicits long-lasting immunological memory in recovered individuals. In this work, we aimed to assess the maintenance of immunological memory to SARS-CoV-2. Methods: We evaluated the long-term virus-specific cellular and humoral immune response in the members of an Italian Serie A football team, who experienced a cluster of COVID-19 in March 2020, which was strictly evaluated in the following months. Results: Our results highlight a heterogeneous magnitude of immunological memory at 5 months after infection. Indeed, 20% of the subjects displayed a weak cellular and humoral memory to SARS-CoV-2, suggesting that they may be at higher risk of reinfection. In addition, a history of symptomatic COVID-19 was associated with higher levels of SARS-CoV-2-reactive CD4+ T cells and specific antibody levels than in asymptomatic individuals. Conclusion: Collectively, these data demonstrate that immunity to SARS-CoV-2 is maintained five months postinfection even if the magnitude of response is heterogeneous among individuals. This finding suggests that some COVID-19-recovered subjects may benefit from vaccination.
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals / Mazzoni A., Maggi L., Capone M., Vanni A., Spinicci M., Salvati L., Tekle Kiros S., Semeraro R., Pengue L., Colao M.G., Magi A., Rossolini G.M., Liotta F., Cosmi L., Bartoloni A., Annunziato F.. - In: CLINICAL AND TRANSLATIONAL IMMUNOLOGY. - ISSN 2050-0068. - ELETTRONICO. - 10:(2021), pp. e1281-e1281. [10.1002/cti2.1281]
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals
Mazzoni A.;Maggi L.;Capone M.;Vanni A.;Spinicci M.;Salvati L.;Semeraro R.;Pengue L.;Magi A.;Rossolini G. M.;Liotta F.;Cosmi L.;Bartoloni A.;Annunziato F.
2021
Abstract
Objective: Although the adaptive immune response to SARS-CoV-2 has been characterised in the acute and early convalescent phase of the disease, few studies explore whether natural infection elicits long-lasting immunological memory in recovered individuals. In this work, we aimed to assess the maintenance of immunological memory to SARS-CoV-2. Methods: We evaluated the long-term virus-specific cellular and humoral immune response in the members of an Italian Serie A football team, who experienced a cluster of COVID-19 in March 2020, which was strictly evaluated in the following months. Results: Our results highlight a heterogeneous magnitude of immunological memory at 5 months after infection. Indeed, 20% of the subjects displayed a weak cellular and humoral memory to SARS-CoV-2, suggesting that they may be at higher risk of reinfection. In addition, a history of symptomatic COVID-19 was associated with higher levels of SARS-CoV-2-reactive CD4+ T cells and specific antibody levels than in asymptomatic individuals. Conclusion: Collectively, these data demonstrate that immunity to SARS-CoV-2 is maintained five months postinfection even if the magnitude of response is heterogeneous among individuals. This finding suggests that some COVID-19-recovered subjects may benefit from vaccination.| File | Dimensione | Formato | |
|---|---|---|---|
|
Clin Trans Imm - 2021 - Mazzoni - Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
933.81 kB
Formato
Adobe PDF
|
933.81 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



